India’s Sun Pharmaceuticals Ltd said on Monday, Dec 18 that it has agreed to acquire a 16.7 percent stake in US company Lyndra Therapeutics Inc for $30 million.
Lyndra Therapeutics, based in Massachusetts, is engaged in the business of developing novel delivery technology for long-acting oral (LAO) therapies.